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Abstract  
Aims: The Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD) 
Axis I diagnostic algorithms were demonstrated to be reliable but below target sensitivity 
of > 0.70 and specificity of > 0.95.  Empirical data supported Axis I algorithm revisions 
that were valid.  Axis II instruments were shown to be both reliable and valid. An 
international consensus workshop was convened to obtain recommendations and 
finalization of new Axis I diagnostic algorithms and new Axis II instruments.   
Methods: A comprehensive search of published TMD diagnostic literature was followed 
by review and consensus via a formal structured process by a panel of experts for 
revision of the RDC/TMD. The panel’s recommendations for revision of the diagnostic 
algorithms were assessed for validity using available data.  
Results: The recommended Diagnostic Criteria for TMD (DC/TMD) Axis I protocol 
includes both a valid screener for pain diagnoses and valid criteria (sensitivity > 0.80, 
specificity > 0.95) for the most common pain-related TMDs and for one intra-articular 
disorder. Diagnostic criteria for other common intra-articular disorders lacked adequate 
validity for clinical diagnoses but can be used for screening purposes. The Axis II 
protocol retains selected RDC/TMD screening instruments augmented with new 
instruments to better assess the interactions between pain and psychosocial 
functioning.  A comprehensive classification system is also presented. 
Conclusion: The recommended evidence-based DC/TMD protocol is appropriate for 
use in both the clinical and research settings. Simple Axis I and II screening tests 
augmented by validated Axis I and Axis II instruments allow for identification of simple to 
complex TMD patients.  
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Introduction 
Temporomandibular disorders (TMD) are a significant public health problem affecting 
approximately 5 to 12% of the population.1 TMD is the second most common 
musculoskeletal condition (after chronic low back pain) resulting in pain and disability.1 
Pain-related TMD can impact the individual’s daily activities, psychosocial functioning, 
and quality of life. Overall, the annual TMD management cost in the USA, not including 
imaging, has doubled in the last decade to $4 billion.1 
Patients often seek consultation with dentists for their TMD, especially pain-related 
TMD.  A dual Axis Diagnostic Criteria for TMD (DC/TMD) with simple, clear operational 
definitions for the history, examination and imaging procedures are needed to render 
Axis I physical diagnoses in both clinical and research settings. Axis II biobehavioral 
assessment of pain-related behavior and psychosocial functioning - an essential part of 
the diagnostic process - provides the minimal information whereby the patient’s pain 
disorder, especially when chronic, warrants further multidisciplinary assessment. A valid 
DC/TMD will provide evidence-based criteria for the clinician to use when assessing 
patients and facilitate communication regarding consultations, referrals, and prognosis.2  
The research community benefits from well-defined and clinically relevant 
characteristics associated with the phenotype. When clinicians and researchers use the 
same criteria, taxonomy and nomenclature, then clinical questions and experience can 
be more easily transferred into relevant research questions, and research findings are 
more accessible to clinicians to better diagnose and manage their patients.  
The Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD) 
has been the most widely employed diagnostic protocol for TMD research since its 
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publication in 1992.3 This classification system was based on the biopsychosocial 
model of pain,4  and this system included an Axis I physical assessment, using reliable 
and well operationalized diagnostic criteria, and an Axis II assessment of psychosocial 
status and pain-related disability. The intent was to simultaneously provide a physical 
diagnosis and identify other relevant characteristics of the patient that could influence 
the expression and thus management of their TMD. Indeed, the longer the pain persists, 
the greater the potential for patients to develop or amplify pre-existing cognitive, 
psychosocial, and behavioral risk factors with enhanced pain sensitivity, greater 
likelihood of pain persistence, and reduced probability of success from standard 
treatments. 
The RDC/TMD was intended to be only a first step toward improved TMD 
classification, and the authors stated the need for future investigation of the accuracy of 
the Axis I diagnostic algorithms in terms of reliability and criterion validity – the latter 
involving use of credible reference standard diagnoses, and to further assess the 
clinical utility of the Axis II instruments. The RDC/TMD Axis I physical diagnoses have 
content validity based on the critical review by experts of the published diagnostic 
approaches in use at that time and were tested using population-based epidemiological 
data.5 Subsequently, a multicenter study showed that, for the most common TMD, 
RDC/TMD diagnoses exhibited sufficient reliability for clinical use.6 While the validity of 
individual RDC/TMD diagnoses has been extensively investigated, assessment of the 
criterion validity for the complete spectrum of RDC/TMD diagnoses had been absent 
until recently.7  
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For the Axis II instruments, good evidence for their reliability and validity for 
measuring psychosocial status and pain-related disability already existed when the 
classification system was published.8-12 Subsequently, a variety of studies have 
demonstrated the significance and utility of the RDC/TMD biobehavioral measures in 
predicting outcomes of clinical trials, escalation from acute to chronic pain, and 
experimental laboratory measures.13-19 Other studies have shown that the RDC/TMD 
biobehavioral measures are incomplete in terms of better prediction of disease course20-
22 The overall utility of the biobehavioral measures in routine clinical settings has, 
however, yet to be demonstrated, in part because most such studies have to date 
focused on Axis I concerns rather than biobehavioral concerns. 23  
The aims of this paper are to present the new evidence-based Axis I and II 
DC/TMD, to be used in both clinical and research settings, as well as the processes 
related to their development.  
 
Methods 
The National Institute of Dental and Craniofacial Research (NIDCR), recognizing the 
need to rigorously assess the diagnostic accuracy of the dual axis RDC/TMD, funded 
the multi-site Validation Project in 2001 that resulted in a dataset of 705 participants 
who were classified, based on reference standard diagnoses, into 614 TMD cases and 
91 controls.24 A description of the demographics, clinical characteristics and 
methodology is available.24-26 Reference standard diagnoses were established by 
consensus between 2 TMD and orofacial pain experts using a comprehensive history, 
physical examination, and imaging studies (panoramic radiograph, and bilateral 
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temporomandibular joint [TMJ] magnetic resonance imaging [MRI] and computed 
tomography [CT]).  Acceptable validity was defined a priori as sensitivity > 0.70 and 
specificity > 0.95.3 When the RDC/TMD Axis I TMD diagnoses were compared to these 
reference standard diagnoses, the findings supported the need for revision of these Axis 
I TMD diagnostic algorithms to improve their diagnostic accuracy.7 The Validation 
Project subsequently developed and validated revised Axis I diagnostic algorithms for 
myofascial pain and arthralgia that have excellent diagnostic accuracy.26 However, 
revised diagnostic algorithms alone, without recourse to TMJ imaging, were still 
inadequate for valid diagnoses of two of the three types of disc displacements (DD) and 
for degenerative joint disease (DJD). Axis II instruments were shown to be reliable and 
valid for screening for psychosocial distress and pain-related disability, but revision was 
warranted for both increased scope and improved clinical efficiency.27,28   
In July 2008, a symposium at the International Association for Dental Research 
(IADR), “Validation Studies of the RDC/TMD: Progress Towards Version 2”, was 
sponsored by the International RDC/TMD Consortium Network in Toronto.29 
Presentation of the revised RDC/TMD Axis I diagnostic algorithms and Axis II findings 
by the Validation Project’s key investigators was followed with critiques from 
researchers in the areas of radiology, neurology, pain psychology, and TMD and 
orofacial pain.30-35   A mandate emerged from the symposium in support of holding a 
consensus workshop for the development of a DC/TMD.   
In March 2009, the “International Consensus Workshop: Convergence on an 
Orofacial Pain Taxonomy”  was organized by the International RDC/TMD Consortium 
Network (IADR) and the Orofacial Pain Special Interest Group (International Association 
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for the Study of Pain), in Miami in order to address the recommendations from both the 
Validation Project investigators28 and from the 2008 Toronto symposium regarding 
development of the DC/TMD. The Validation Project’s findings and recommendations, 
as well as comprehensive literature searches regarding diagnostic tests, served as the 
basis for the resulting consensus-based recommendations that are available in the 
executive summary. 36,37 The ad-hoc Taxonomy Committee was appointed by the 
workshop participants and charged with finalizing the workshop recommendations; 
these recommendations were then reviewed by the workshop participants for feedback 
and approval. The Validation Project’s findings and recommendations were 
subsequently published.7,24-28  
The Validation Project team used the available dataset from that project, as 
appropriate, to assess validity for the changes to the Axis I diagnostic algorithms as 
recommended by the 2009 Miami workshop. These analyses were then reviewed, 
edited, and approved by members of the Taxonomy Committee.  For the Axis II portion 
of the DC/TMD, the implementation of the consensus report from the 2009 Miami 
workshop was further refined based on recommendations from a subsequent 
workshop38 and recommendations from more recent publications that built upon 
Validation Project findings.27  
In July 2010, the working draft of the DC/TMD was presented to the international 
clinical and research community for critique and comments at a symposium in 
Barcelona, Spain (IADR). Further refinement of select DC/TMD diagnoses occurred in 
2011 at the International RDC/TMD Consensus Workshop (San Diego) at the IADR. 
From 2011-2012, the examiner specifications for the Axis I assessment protocol and the 
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Axis II instruments were field-tested. In 2012, the DC/TMD manuscript was then 
reviewed and finalized by the Miami 2009 workshop participants for publication. 
Detailed information regarding the development of the DC/TMD is available on the 
International RDC/TMD Consortium Network website.39  
Concurrent with the above activities was the development of a new taxonomic 
classification structure. The Taxonomy Committee and selected members of the 2009 
workshop used the taxonomic structures developed by the American Academy of 
Orofacial Pain (AAOP)40 in order to develop the structure used in this manuscript. The 
members of the workshops held in 2011 at San Diego and at the International 
Consensus Workshop:  Expanded TMD Taxonomy for Further Classification Research 
in June 2012 at Iguacu Falls, Brazil (IADR) further refined this more comprehensive 
taxonomic structure and related diagnostic criteria. The AAOP council subsequently 
endorsed this taxonomic structure in 2012. 
 
Results 
Overview. The following recommendations represent an evidence-based DC/TMD 
intended for immediate implementation in clinical and research settings. The diagnostic 
algorithms and estimates of sensitivity and specificity for the most common TMDs are 
presented in Tables 1 and 2.  Common TMDs include myalgia, myofascial pain with 
referral, arthralgia, TMJ disc displacements with and without reduction, TMJ 
subluxation, and TMJ degenerative joint disease.  Decision trees are available which 
map the history and clinical findings to these specific disorders except for TMJ 
subluxation.41 Acceptable sensitivity and specificity for a definitive diagnosis are 
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considered as sensitivity > 70% and specificity > 95%.3 Diagnostic criteria with 
sensitivity or specificity lower than these target values were used when there was no 
available alternative. Table 3 provides an inclusive taxonomic classification structure 
for both common and uncommon TMD. The criteria for the less common types of TMD 
have not been assessed for criterion validity.  The revision of the AAOP criteria40 
presented here has undergone considerable review and has been updated as a result 
of the joint effort by members of the International RDC/TMD Consortium Network and 
the Orofacial Pain Special Interest Group of the IASP.  These revised criteria for the 
less common TMD will be available on the Consortium website.  As with the original 
RDC/TMD Axis I criteria, their diagnostic validity must be rigorously assessed.  The 
Axis II protocol has been expanded by adding instruments to evaluate pain behavior, 
psychological status, and psychosocial functioning.  The inclusion of the biobehavioral 
domain has been well-accepted in the pain field overall, and the specific inclusion of 
Axis II has been recommended as a general model for assessing any pain patient. 42 
Finally, a “stepped” assessment model is embedded in the DC/TMD components, 
allowing the protocol to support assessment ranging from screening to comprehensive 
expert evaluation. 
 
1. Workshop Recommendations for Axis I Pain-related TMD Diagnoses 
A. The Axis I TMD Pain Screener 43 is a simple, reliable and valid self-report 
instrument used to assess for the presence of any pain-related TMD with 
sensitivity and specificity > 0.95.44 A 3-item version is suitable for epidemiological 
studies, while the full 6-item version has reliability sufficient for screening 
individuals for pain-related TMD. The full screening instrument provides one 
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method to obtain the necessary history for rendering a specific diagnosis in 
conjunction with the DC/TMD pain-related diagnostic algorithms (see below). 
B. The changes in the diagnostic algorithms for the pain diagnoses in the DC/TMD, 
as compared to the corresponding disorders in the RDC/TMD, are summarized in 
Table 4.  In the DC/TMD, myalgia has replaced the term myofascial pain, as 
found in the RDC/TMD.  Further detail regarding these changes can be found in 
the Examination Specifications.45 The diagnostic algorithms in the DC/TMD for 
arthralgia and myalgia now include criteria for modification of pain by function, 
movement or parafunction; these criteria are also included in the TMD Pain 
Screener. The clinical exam includes provocation tests for TMJ arthralgia of pain 
with any jaw movement (i.e., opening, excursive, and protrusive) and TMJ 
palpation. For myalgia, the tests include pain with opening jaw movements and 
palpation of the temporalis and masseter muscles. Pain from these provocation 
tests must replicate the patient’s pain complaint.  
C. The sub-disorder of myofascial pain with limited opening, as described in the 
RDC/TMD, is eliminated.  
D.  Myofascial pain with referral is included as a new type of disorder. The palpation 
procedure for eliciting referred pain, as a necessary criterion for this disorder, 
requires sustained pressure for 5 seconds. 
E. For the DC/TMD, muscle pain diagnoses are organized into 4 major subclasses 
(see Table 3). Myalgia is further subdivided into three mutually exclusive types of 
myalgia: local myalgia, myofascial pain, and myofascial pain with referral.  
Sufficient data from the Validation Project existed to estimate the criterion validity 
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for myalgia as a class (sensitivity and specificity of 0.90 and 1.00, respectively) 
and myofascial pain with referral as a type of myalgia (sensitivity and specificity 
of 0.85 and 0.98, respectively). For the other two types of myalgia, local myalgia 
and myofascial pain, the combined sensitivity and specificity are 0.84 and 0.95, 
respectively. The diagnostic criteria for myalgia and myofascial pain with referral 
are listed in Table 1.  Diagnostic criteria for local myalgia and myofascial pain will 
be available on the Consortium website. Therefore, if a diagnosis of myalgia is 
desired, and no distinction between the types is needed, then the more general 
diagnostic procedures are sufficient (see Table 1).  
 
2. Workshop Recommendations for Axis I TMJ Disc Displacement (DD) and 
Degenerative Joint Disease (DJD) 
A. The clinical procedures for assessing DD with reduction, DD without reduction 
without limited opening, and DJD lead to clinical diagnoses based on procedures 
that exhibit low sensitivity but good to excellent specificity.  Consequently, for 
treatment decision-making in selective cases, confirmation of a provisional 
clinical diagnosis requires imaging. In contrast, the clinical procedures for 
assessing DD without reduction with limited opening have acceptable sensitivity 
and specificity, and the clinical evaluation may be sufficient for the initial working 
diagnosis.  
B. The changes made to the diagnostic algorithms in the DC/TMD for DDs and DJD 
as compared to the RDC/TMD are summarized in Table 5. Further detail 
regarding these changes can be found in the Examination Specifications.45 TMJ 
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noise by history is a criterion for the intra-articular disorders of DD with reduction 
and DJD. For DD with reduction, examiner detection of clicking, popping or 
snapping noises during the examination is required. For DJD, the detection of 
crepitus during the examination is required, either by the examiner or by the 
patient with examiner assistance regarding clarification of type of noise present 
(e.g., crunching, grinding or grating noises).  Inclusion of the latter criterion 
improved the sensitivity for this diagnosis from 20% to 49%. For DJD, no 
distinction between fine versus coarse crepitus is made.  Finally, for DD without 
reduction, an assisted opening measurement (including the amount of vertical 
incisal overlap) of <40 mm yields the subtype of “with limited opening” while the 
measurement >40 mm yields the subtype of “without limited opening”, and joint 
noises, if present, do not affect the diagnosis as long as the required criteria are 
met.  
C. DD with reduction with intermittent locking and TMJ dislocation are included as 
new types of disorder.  The diagnostic algorithms for these disorders include 
specific criteria from the patient history including current intermittent locking with 
limited opening and jaw locking in the wide-open position for DD with reduction 
with intermittent locking and TMJ dislocation, respectively. 
D. Nomenclature change: The terms osteoarthritis and osteoarthrosis are 
considered to denote subclasses of DJD. 
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3. Workshop Recommendations for Axis I Headache Disorders 
“Headache attributed to TMD” is included as a new disorder type to replace “Headache 
or facial pain attributed to temporomandibular joint (TMJ)” disorder as described in the 
International Classification of Headache Disorders II (ICHD II).46 The diagnostic 
algorithm for Headache attributed to TMD has been previously published. 47 
 
4. Workshop Recommendations for Axis II Evaluation.  
It is well recognized that the patient’s cognitive, emotional, and behavioral response to 
pain are quite independent of the source of their pain so the workgroup recommended 
the use of instruments currently used in other areas of medicine to assess the 
psychosocial functioning associated with any pain condition.  In addition, the Jaw 
Functional Limitation Scale was selected to assess jaw function specific to TMD. The 
criteria used to select the additional Axis II instruments were reliability, validity, 
interpretability, patient and clinician acceptability, patient burden, and feasibility as well 
as availability of translated versions for different languages and cultures. All areas of 
biopsychosocial assessment with the recommended instruments are available from the 
Consortium 48,49 and are summarized in Table 6. 
A. Axis II screeners. Three simple self-report screening instruments are included for 
detection of pain-relevant psychosocial and behavioral functioning. The Patient 
Health Questionnaire-4 (PHQ-4) is a short, reliable, and valid screening 
instrument for detecting “psychological distress” due to anxiety and/or depression 
in patients in any clinical setting.50 A cutoff of > 6, suggesting moderate 
psychological stress, should be interpreted as warranting observation, while a 
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cutoff of > 9, suggesting severe psychological distress, should be interpreted as 
warranting either further assessment or referral.50 The Graded Chronic Pain 
Scale (GCPS) is a short, reliable, and valid instrument that assesses pain 
intensity and pain-related disability.9 The two GCPS subscales are Characteristic 
Pain Intensity (CPI) that reliably measures pain intensity with ≥ 50/100 
considered “high intensity” and the pain-disability rating is based on number of 
days that pain interferes with activity and on interference with social, work, or 
usual daily activities. High pain and high interference, or moderate to severe 
disability (classified as Grades 3 or 4) should be interpreted as disability due to 
pain, warranting further investigation and suggests a possible complex patient 
where the individual is experiencing significant life impact from the TMD. The 
third instrument is a pain drawing of the head, jaw and body and it allows the 
patient to report the location of all pain complaints.51,52 Widespread pain 
suggests the need for comprehensive assessment of the patient. 
B.  Additional assessment instruments.  The reliable and valid Jaw Functional 
Limitation Scale (JFLS) has a short form that assesses global limitations across 
mastication, jaw mobility, and verbal and emotional expression.53,54 The Oral 
Behaviors Checklist (OBC) assesses the frequency of oral parafunctional 
behaviors.55,56 
C. Comprehensive Axis II Instruments.  The remaining instruments to be used when 
indicated by specialists or researchers in order to obtain a more comprehensive 
evaluation of psychosocial functioning are listed in Table 6 and follow the 
Initiative on Methods, Measurements and Pain Assessment in Clinic Trials 
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 20 
(IMMPACT) recommendations.57 Those recommendations include assessment of 
pain intensity, physical functioning (both general and disease-specific), and 
emotional functioning. In addition to measuring pain intensity and disease-
specific physical functioning (via GCPS and JFLS, respectively, as described 
above), the DC/TMD includes new measures for a more comprehensive 
assessment of emotional functioning using the PHQ-958 for depression (with 
cutoffs of 5, 10, 15, and 20 representing, respectively, mild, moderate, 
moderately severe, and severe levels of depression) and GAD-759 for anxiety 
(with cutoffs of 10 and 15 representing, respectively, moderate and severe levels 
of anxiety).  Finally, like the RDC/TMD, the DC/TMD retains a measure for 
physical symptoms using the PHQ-15 60 (with cutoffs of 5, 10, and 15 
representing, respectively, low, medium, and high somatic symptom severity) 
due to the overwhelming importance of overall symptom reporting in individuals 
with TMD.61 The SCL90-based measures in the RDC/TMD were replaced in the 
DC/TMD for several reasons: length, public-domain, and application to medical 
settings. 
 
5. Data Collection Forms and Examination Specifications. A short, focused Patient 
History Questionnaire (PHQ)62 was developed to assess pain intensity as well as 
history of jaw noise, jaw locking, and headache potentially to be attributed to TMD. 
The PHQ provides the necessary history for the Axis I diagnostic criteria. The 
DC/TMD operational specifications for the clinical tests, examination forms, PHQ, 
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and biobehavioral assessment instruments can be downloaded from the 
Consortium website37 and used without copyright infringement. 
 
Discussion 
The DC/TMD is an evidence-based assessment protocol that can be immediately 
implemented in the clinical and research setting. Compared to the RDC/TMD, the 
DC/TMD is easier to use, includes valid Axis I and Axis II patient screeners, and 
provides valid Axis I diagnostic algorithms for the most common TMD as part of a 
comprehensive TMD taxonomic classification structure.  Axis I core assessment 
instruments assess history of jaw noise and locking, and headache attributed to TMD; 
Axis II core assessment instruments assess pain intensity, general functioning, jaw 
functioning, psychosocial distress, and potential contributing factors of parafunctional 
behaviors and widespread pain. These changes in the core patient assessment 
instrument set, as compared to the RDC/TMD, continue to serve as a broad foundation 
for patient assessment and further research. The DC/TMD includes important additions, 
deletions and modifications to the original RDC/TMD that deserve comment. These 
changes are a result of research findings and expert contributions from professional 
TMD clinical and research groups guided by the principle to create a parsimonious 
DC/TMD based on the best available evidence. This manuscript cites the core 
assessment instruments that existed at the time of this publication and these 
instruments will be updated as indicated in the future with the most current versions 
available on the Consortium website.37 
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Changes to the RDC/TMD History and Examination  
The criterion for a patient report of pain modified, that is, made better or worse, by jaw 
function, movement or parafunction is now a requirement for all pain-related TMD 
diagnoses; this feature is shared with other musculoskeletal pains.63,64 Questions 
regarding pain modification are integral to the history provided by the TMD Pain 
Screener or by the more comprehensive DC/TMD Patient History Questionnaire that 
contains all of the history questions required for the DC/TMD diagnostic algorithms.  
Pain modification is especially important in differential diagnosis in a broader clinical 
setting when co-morbid conditions may be present, especially other trigeminal system-
mediated pain conditions.  
The clinical provocation of “familiar pain” has proved useful in the assessment of 
other orthopedic and pain disorders.65-71 The rationale is that the clinician needs to 
provoke the patient’s pain complaint in order for a positive examination response to be 
clinically meaningful.  A patient report of “familiar pain” is required with pain provoked by 
jaw movement and/or palpation to diagnose pain-related TMD including arthralgia, 
myalgia and myofascial pain with referral. “Familiar pain” is pain that is like or similar to 
the pain the patient has been experiencing.  The intent is to replicate the patient’s chief 
complaint of pain(s) in such a way that the patient describes that provoked pain in the 
same way – because it is the same type of pain. This criterion minimizes false positive 
findings from pain provoking tests in asymptomatic patients and incidental findings in 
symptomatic patients.  Similarly, a report of “familiar headache” is required from the 
examination as part of the diagnostic algorithm for what is termed “Headache attributed 
to TMD”.   It must, however, be emphasized that the presence of “familiar pain” is not 
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associated exclusively with the diagnoses of myalgia, myofascial pain with referral, or 
arthralgia, as other conditions may cause “familiar pain” during jaw movement or from 
palpation of jaw structures such as muscle or joint.  For example, rheumatoid disease 
affecting the TMJ and infection can result in the report of “familiar pain” from movement 
and/or palpation of the associated structures.  In order for the criterion of “familiar pain” 
to lead logically to the specified diagnosis, the signs must explain the symptoms; the 
symptom history, or additional assessment, must effectively rule out other competing 
diagnoses.72  
For myalgia and myofascial pain with referral diagnoses, palpation of only the 
temporalis and masseter muscles is required; mandatory palpation of the temporalis 
tendon, lateral pterygoid area, submandibular region, and posterior mandibular region 
has been eliminated because of poor reliability,73-75 and not examining these areas does 
not significantly affect the validity of these diagnoses.26 For example, the lateral 
pterygoid is commonly tender in non-cases, leading to false positives in the 
RDC/TMD.73 It is also uncommon for these other sites to be painful to palpation when 
the masseter or temporalis muscles are not, but they may be used when clinically 
indicated. For the same reason, palpation of the posterior aspect of the TMJ through the 
external auditory meatus has also been eliminated but can also be used when clinically 
indicated.  
TMJ noises can be difficult to detect, even with auscultation using a stethoscope, 
and can be sporadically present. For DJD, including patient report of crepitus during the 
examination with guidance from the clinician substantially improves its diagnostic 
accuracy.26 Patient report of noises such as crunching, grinding or grating noises (i.e., 
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crepitus) typically requires reviewing these noises with the patient and then carefully 
interpreting their responses.  The distinction between coarse and fine crepitus was 
omitted as these sounds are not reliably distinguished and the distinction does not 
contribute to DJD’s diagnostic validity.  
Changes to the RDC/TMD Pain Diagnoses  
The RDC/TMD diagnosis of myofascial pain with limited opening has not yet 
demonstrated unique clinical utility and was eliminated.  The remaining RDC/TMD 
diagnosis of myofascial pain has been reorganized in the DC/TMD into two new 
validated disorders: myalgia (as a subclass of muscle pain disorders) and myofascial 
pain with referral (as a type of myalgia); see Table 3. Myofascial pain with referral is a 
distinct clinical disorder with central convergence accounting for the referral of pain to 
other anatomical sites.76-78 Referred pain has clinical utility for, at a minimum, differential 
diagnosis regarding the identification of pain in other anatomical locations, including 
referred pain to the teeth, that is ultimately pain of muscular origin. 
The term “Headache Attributed to TMD” is a new Axis I diagnostic 
classification.79 Tension-type headache (TTH) and migraine have been associated with 
TMD.18,80-87 In particular, TTH and TMD share many symptoms,18,87,88 although this may 
not imply identical pathophysiology or underlying mechanisms.85,88,89 A subgroup of 
headache patients experience increased headache following masticatory system 
provocation such as clenching of the teeth (i.e., parafunctional behaviors).85,86,89,90 
Longitudinal studies have found that the development of TMD was accompanied by an 
increase in headache and that the presence of TMD at baseline predicted the onset of 
headache.91,92 Finally, treatment of the masticatory system has also been associated 
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with a report of decreased headaches. These findings suggest that some headaches 
may be secondary to TMD.93-95   
Frequency of TTH96 and migraine correlate with functional disability and is a 
useful patient characterization,97-99 and increased frequency of headaches in the 
temples is associated with increased symptoms of painful TMD.99  Future research will 
explore whether sub-classification of headache attributed to TMD, arthralgia and 
myofascial pain in terms of frequency of pain occurrence can also improve the 
identification of patients with more complex pain problems.  Consequently, frequency 
and duration of “jaw pain” is included in a longer version of the DC/TMD Patient History 
Questionnaire, available on the Consortium website.  
Changes to the RDC/TMD TMJ Diagnoses   
A diagnostic category of DD with reduction with intermittent limited opening (i.e., 
episodic self-limiting “closed lock”) was included in the DC/TMD. This is a common, 
clinically significant mechanical joint disorder that can require treatment. Another newly 
included diagnostic category is the mechanical joint disorder TMJ dislocation 
characterized by “open lock” of the jaw and typically diagnosed based on patient history. 
If the patient is able to reduce this dislocation it is termed “subluxation,” and if the 
dislocation requires an interventional reduction it is termed “luxation”. Sufficient data 
were only available to assess the diagnostic validity of subluxation.100  
The low sensitivity for the diagnostic algorithms for DD and DJD suggest these 
criteria be limited to providing provisional diagnoses. For example, for a diagnosis of DD 
with reduction, a positive history of noise and the presence clinically of clicking noises 
(as specified) effectively rules in the diagnosis due to the criteria’s high specificity, while 
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a negative finding can be associated with false negatives due to low sensitivity. That is, 
some DD with reduction will not have clinically detectable noise, have fewer clicks or 
different types of noise, and will not be diagnosed using the clinical criteria.101 Based on 
available data, DD with reduction are highly prevalent and are probably without clinical 
consequence in the absence of pain occurring with the noise, or presence of functional 
limitations such as limited opening or interference in mastication. Nevertheless, imaging 
using MRI and CT is required for a definitive diagnosis of TMJ DD and DJD, 
respectively, and especially when the DC/TMD leads to a negative outcome in 
association with a clinical history that suggests a clinically important disc–condyle 
complex disorder. The single diagnostic exception is DD without reduction with limited 
opening (i.e., “closed lock”), which shows good diagnostic validity without imaging (i.e., 
sensitivity 80%; specificity 97%). However, the criteria for DD without reduction with 
limited opening have not been assessed with subjects with other causes of limited 
opening (e.g., adhesions, coronoid hyperplasia or muscle contracture).  The need for a 
definitive DD diagnosis, and thus the indication to use imaging is based on whether the 
information gained will change the patient’s treatment plan or prognosis. Reliable 
imaging criteria for these disorders are available.102 
Taxonomic Classification Structure and Classification of the less common TMDs 
A comprehensive taxonomic system is presented in Table 3. The diagnostic criteria for 
the less common TMD were derived from the AAOP guidelines augmented with the best 
available definitions for those TMD as well as those TMD not identified by the AAOP 
guidelines. These criteria will be available on the Consortium website where they can be 
continually updated as new information emerges. The AAOP-based diagnostic criteria 
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were developed by clinicians and researchers based on their experience and the 
literature.40 However, as these criteria have not been assessed for diagnostic accuracy, 
special caution should accompany clinical use.  Treatment decisions based on these 
diagnoses should be undertaken with careful consideration of all risks and benefits 
associated with the resulting care plan.  
Nomenclature  
Since the terms osteoarthrosis and osteoarthritis have not been consistently used in 
medicine, these terms were subclassified under the broader term DJD. Use of DJD is 
also endorsed by the American Association of Oral and Maxillofacial Surgeons.103 When 
pain co-occurs with DJD, the additional diagnosis of “arthralgia” can be used – as is the 
case with DD. A former diagnosis of osteoarthritis by the RDC/TMD is now dually coded 
as both degenerative joint disease and joint pain. 
Changes to RDC/TMD Axis II  
IMMPACT guidelines for clinical trials assessing pain recommend that patients be 
assessed for pain intensity and emotional functioning as well as general and “disease 
specific” physical functioning.57 These four domains are assessed using the core Axis II 
instruments of GCPS (pain intensity subscale), PHQ-4 (emotional functioning), GCPS 
(general physical functioning using the interference subscale) and the JFLS (disease 
specific physical functioning). The primary Axis II domains from the RDC/TMD have 
been retained but are now measured more efficiently. Domains that bridge behavior 
with Axis I and are of direct utility for the clinician and researcher have been added.  
The biopsychosocial model of pain recognizes that pain is not purely a sensory process 
but that it is always accompanied by cognitive, emotional, and behavioral aspects that 
 28 
influence how a patient reacts to and reports pain, and that, in turn, result in coping 
strategies that may be helpful or harmful in maintaining adequate functioning. If these 
coping strategies are harmful, they can contribute to the development of chronic pain.  
Indeed, a set of psychosocial factors such as anxiety, depressed mood, psychological 
distress, fear-avoidance beliefs, catastrophic thoughts, passive coping strategies, and 
social isolation have been recognized as risk factors for the development of chronic pain 
in musculoskeletal disorders.104-106 Similar risk factors have also been identified for 
chronicity in individuals with TMD.17,61,107,108   
In addition, psychosocial factors are at least as important for the treatment 
outcome as are initial pain intensity and physical diagnoses.109,110 The expansion of 
Axis II instruments for the DC/TMD serves to better evaluate the patient’s psychosocial 
and behavioral status in order to identify the presence of these risk factors that must be 
addressed from the beginning of any treatment and thereby decrease the risk of the 
patient developing chronic pain.105,111 Core risk factor assessment instruments include 
the OBC to identify maladaptive parafunctional behaviors and the pain drawing to 
readily identify presence of widespread pain or other regional pain conditions.  Frequent 
maladaptive parafunctional behaviors appear to create repetitive trauma to the 
masticatory system, and when the patient cannot learn to control them, the presence of 
significant psychosocial distress should be considered as another co-morbid condition 
contributing to the persistence of the disorder. Widespread pain suggests potential 
systemic disorders including rheumatic diseases and/or central sensitization (e.g., 
fibromyalgia) suggesting the need for further medical assessment. It is therefore 
advisable that the core set of Axis II instruments be used routinely in all clinical 
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assessments. Their use in the clinical setting will facilitate the prevention of chronicity 
among individuals with recent onset TMD and will result in more efficient management 
of chronic TMD.   
An in-depth evaluation of the patient’s psychosocial status is important for all 
research studies comparing TMD treatment modalities.  Otherwise, it is difficult to 
foresee how such research that does not take into account important risk factors can 
improve our understanding of TMD and provide us with the treatment of choice.23 This is 
because Axis II psychosocial factors have better prognostic value then Axis I physical 
diagnoses.17,108 
Clinical Application of the DC/TMD  
The comprehensive evaluation necessary to design a specific patient’s care plan is 
beyond the scope of this paper; the reader is referred to a clinical assessment 
protocol72, for example, within which the DC/TMD can be used. Before using the 
DC/TMD, other orofacial pathology, including odontogenic pathology, trigeminal 
autonomic dysfunction cephalalgias, other headache disorders, and neuropathic pain 
disorders needs to be ruled out.  An “unusual” presentation such as swelling, warmth 
and redness, autonomic signs, or sensory or motor deficiencies warrants high 
suspicion, since these are not typical TMD signs.  The DC/TMD is an effective and 
efficient adjunct to well-developed clinical reasoning skills, keeping in mind that the 
history must lead to a provisional diagnosis and the clinical examination, augmented 
when indicated by other assessment tools, is needed to confirm or refute this 
provisional diagnosis.  The validity of the diagnostic criteria revolves around use of 
reliable clinical tests; several versions of the clinical procedures are available on the 
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Consortium website.45   Finally, multiple diagnoses are permitted: one of the muscle 
pain diagnoses (myalgia or myofascial pain with referral), as well as diagnoses for each 
joint (a joint pain diagnosis, any one of four disc displacement diagnoses, a 
degenerative joint disorder diagnosis, and/or a subluxation diagnosis).  In addition to the 
formal DC/TMD diagnoses for the common disorders, other diagnoses as listed in Table 
3 may be required in order to fully capture all findings; for example, a lateral pterygoid 
spasm could co-exist with a myalgia of the other masticatory muscles, resulting in two 
muscle diagnoses. 
The DC/TMD assessment protocol has both screening and confirmatory tests for 
the most common Axis I physical diagnoses and for Axis II contributing factors (see 
Table 7). The Axis I TMD Pain Screener is recommended for all patients in any clinical 
setting.44 A positive screen is followed by further evaluation to arrive at the specific TMD 
pain-related diagnoses.  The Axis II screening instruments consist of 11 questions from 
the PHQ-4 and GCPS as well as a pain drawing with minimal burden to the patient and 
clinician;9,50 their use is recommended when triage indicates a pain disorder is present, 
and their use should be considered mandatory in case of persistent pain lasting 6 
months or longer or in the presence of prior unsuccessful treatment(s).  Overall, the 
Axis II screening instruments identify barriers to treatment response, contributors to 
chronicity, and targets for further intervention.14,15 Positive findings with these screening 
instruments require further investigation using either the comprehensive Axis II 
assessment instruments listed in Table 6, or referral to the patient’s physician or a 
qualified mental health provider, ideally a health psychologist and/or psychiatrist 
depending on the findings from this assessment.112 Deleted: 111
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The final two Axis II instruments can be used with any patient. The OBC 
assesses for the presence of parafunctional behaviors which may be a form of trauma 
to the masticatory system.113  Likewise, the JFLS can be used to identify jaw related 
functional limitations that may be present in any patient and then can be used to 
document changes over time. Axis II instruments and their application are discussed 
more fully elsewhere.27,28,114 All Axis II instruments are available on the Consortium 
website. 
Adjunctive Tests  
The DC/TMD provides the core provocation tests necessary for the diagnosis of 
masticatory muscle and TMJ pain but false positives and negatives can occur. 
Adjunctive tests may include static and dynamic tests, joint play tests such as 
compression and distraction, bite tests, “end-feel” tests, clenching tests, and palpation 
of the other masticatory muscles that are not part of the core criteria115-121 Even though 
these tests did not improve overall validity of the diagnostic algorithms, they may, 
nevertheless, be useful in specific circumstances where the history suggests a pain-
related TMD and the formal DC/TMD examination protocol is negative.26,119,121,122 When 
used, these adjunctive tests must also provoke “familiar pain”. Occlusal tests also did 
not contribute to the diagnostic validity of any of the TMDs, but occlusal factors 
including intercuspal occlusal contacts, open bite, and the slide from centric relation to 
maximum intercuspal position can all be affected by DD and DJD123 and documentation 
of occlusal status during initial assessment is warranted.  The history and clinical 
examination remains the cornerstone for TMD diagnosis, and all adjunctive tests, 
including electronic diagnostic instruments, require assessment for their diagnostic 
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accuracy and evidence of incremental validity for a true positive diagnosis of TMD prior 
to being recommended for clinical use.124-126  
Patient advocacy 
The workshop had the benefit of obtaining patient advocate input.  A paradigm shift was 
advocated from a doctor-based assessment to patient-reported assessment.  In short, 
patients want their symptom experience to be a more central part of the assessment 
and treatment recommendations. For example, limited mouth opening has been 
traditionally assessed using less than 40 mm as a “cut-off” and recent population based 
study involving more than 20,000 individuals supports this cutoff.127 An alternative 
perspective is to ask the patient if they perceive a limitation in their opening independent 
of this “cut-off”. Ultimately, what the patient believes, feels and reports is as important 
as what the clinician is able to observe and measure.   
Future Directions 
The DC/TMD, like the RDC/TMD, needs to be further tested and periodically 
reassessed to make appropriate modifications to maximize its full value as new 
research findings are reported. Ongoing changes and updates to the DC/TMD will be 
managed and available through the International RDC/TMD Consortium Network. We 
encourage the larger TMD community to make recommendations for its development 
including developing assessment tools for use in children and adolescents, validate the 
DC/TMD in diverse settings, and expand the Axis II tools in order to contribute to the 
ongoing development of its validity - and clinical utility.   
In terms of immediate goals, ongoing processes through the Consortium include 
further development of the taxonomy for Axis I conditions and critical review of Axis II 
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constructs and instruments.  Research regarding the ontological structure of both Axis I 
and Axis II concepts is ongoing in order to develop more logical taxonomic concepts. 
Axis III is being developed for identifying clinically relevant biomarkers such as 
quantitative sensory measures as well as genomic or molecular profiles. Finally, an Axis 
IV is envisioned as a method to classify a patient into clinically meaningful categories by 
collapsing large amounts of variability across biopsychosocial and molecular genomic 
domains through, for example, the use of modern clustering models.128  
Although the DC/TMD will be in important tool for future research projects 
addressing the underlying TMD mechanisms and etiologies, the DC/TMD has 
limitations. It is now recognized that TMD is a heterogenous group with manifestations 
well beyond the signs and symptoms associated with the current Axis I diagnoses. TMD 
is frequently associated with complaints indicating one or more other persistent pain 
conditions.10,129  This fact requires a broader assessment of TMD patients beyond Axis 
I, and it underlies the significance of Axis II and the current development of Axis III.  A 
more comprehensive medical assessment of co-morbid physical disorders and 
biobehavioral status with expansion of Axis II risk determinants for TMD will allow for 
identifying subpopulations of patients based on underlying pathophysiological 
mechanisms.130  This will lead to development of new algorithms and new diagnostic 
categories that are based on etiologies and a parallel classification based on 
mechanisms.  Consequently, we expect that such categories, including the associated 
diagnostic procedures, will contribute to the development of personalized treatments for 
TMD patients - and other related conditions with a high comorbidity with TMD.  We are 
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at the beginning of a new horizon that shows great promise in producing new diagnostic 
procedures and treatment modalities for TMD and other inter-related conditions. 
 
Conclusions 
The DC/TMD is intended for use within any clinical setting and supports the full range of 
diagnostic activities from screening to definitive evaluation and diagnosis. The DC/TMD 
provides a common language for all clinicians while providing the researcher with the 
methods for valid phenotyping of their subjects – especially for pain-related TMD.  
Although the validity data identifies the need for imaging in order to obtain a definitive 
TMJ-related diagnosis, imaging should not be used routinely but rather considered 
when it is important to a specific patient or a research question. The Axis II screeners 
provide the clinician with an easy method to screen for pain intensity, psychosocial 
distress and pain-related disability in order to plan treatment and consider prognosis.  
The additional Axis II instruments, a core part of all TMD assessments, provide the 
clinician and researcher with current methods to further assess the status of the 
individual regarding multiple risk factors relevant to pain management. The DC/TMD is 
a necessary step towards the ultimate goal of developing a mechanism- and etiology-
based DC/TMD that will more accurately direct the clinician in providing personalized 
care for their patients. 
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Table 1. Diagnostic Criteria for the Most Common  
Pain-Related Temporomandibular Disorders 
 
Myalgia (ICD-9 729.1) 
Description 
Pain of muscle origin that is affected by jaw movement, function, or parafunction, and  
replication of this pain occurs with provocation testing of the masticatory muscles.  
Cr
ite
ria
 
HISTORY 
1.  Pain1 in the jaw, temple, in the ear, or in front of ear; AND 
2.  Pain modified with jaw movement, function or parafunction. 
AND 
1. Confirmation2 of pain location in the area of the temporalis or masseter muscle(s); 
AND  
2. Report of familiar pain3 in the temporalis or masseter with at least 1 of the 
following provocation tests: 
a. Palpation of the temporalis or masseter muscle(s); OR 
b.  Maximum unassisted or assisted opening. 
EXAM 
Validity Sensitivity 0.90; Specificity 1.00 
Comments The pain is not better accounted for by another pain diagnosis.  Other masticatory 
muscles may be examined as dictated by clinical circumstances but the sensitivity and 
specificity for this diagnosis based on these findings has not been established.  
 
Myofascial Pain with Referral (ICD-9 729.1) 
Description 
Pain of muscle origin as described for myalgia, with referral of pain beyond the 
boundary of the masticatory muscle(s) being examined when using the myofascial 
examination protocol. Myofascial pain with referral is a subtype of myalgia. 
Cr
ite
ria
 
HISTORY 
1.  Pain1 in the jaw, temple, in the ear, or in front of ear; AND 
2.  Pain modified with jaw movement, function or parafunction. 
AND 1.  Confirmation2 of pain location in the area of the temporalis or masseter muscle(s); 
AND 
2.  Report of familiar pain3 with palpation of the temporalis or masseter muscle(s); 
AND 
3.  Report of pain at a site beyond the boundary of the muscle(s) being palpated. 
EXAM 
Validity Sensitivity 0.85; Specificity 0.98 
Comments The pain is not better accounted for by another pain diagnosis. Other masticatory 
muscles may be examined as dictated by clinical circumstances  but the sensitivity and 
specificity for this diagnosis based on these findings has not been established.  
 
1 The time frame for assessing pain including headache is in “the last 30 days” since the stated sensitivity and specificity of these 
criteria were established using this time frame. Although the specific time frame can be dependent on the context in which the 
pain complaint is being assessed, the validity of this diagnosis based on different time frames has not been established. 
2 The examiner must identify with the patient all anatomical locations that they have experienced pain in the last 30 days. For a 
given diagnosis, the location of pain induced by the specified provocation tests must be in an anatomical structure consistent 
with that diagnosis.  
3 “Familiar pain” (or headache) is based on patient report that the pain induced by the specified provocation test(s) has 
replicated the pain that the patient has experienced in the time frame of interest, which is usually the last 30 days. “Familiar 
pain” is pain that is similar or like the patient’s pain complaint.   
 
Arthralgia (ICD-9 524.62) 
Description 
Pain of joint origin that is affected by jaw movement, function, or parafunction, and 
replication of this pain occurs with provocation testing of the TMJ. 
Cr
ite
ria
 
HISTORY 
1.  Pain1 in the jaw, temple, in the ear, or in front of ear; AND 
2.  Pain modified with jaw movement, function or parafunction. 
AND 1.  Confirmation2 of pain location in the area of the TMJ(s); AND 
2.  Report of familiar pain3 in the TMJ with at least 1 of the following provocation 
tests: 
a.  Palpation of the lateral pole or around the lateral pole; OR 
b.  Maximum unassisted or assisted opening, right or left lateral movements, or 
protrusive movements 
EXAM 
Validity Sensitivity 0.91; Specificity 0.96 
Comments The pain is not better accounted for by another pain diagnosis.  
 
Headache attributed to TMD (ICD-9 339.0) 
Description 
Headache in the temple area secondary to pain-related TMD*  that is affected by jaw 
movement, function, or parafunction, and replication of this headache occurs with 
provocation testing of the masticatory system. 
Cr
ite
ria
 
HISTORY 
1. Headache1 of any type in the temple, AND 
2. Headache modified with jaw movement, function or parafunction. 
 AND 1. Confirmation2 of headache location in the area of the temporalis muscle(s); AND 
2. Report of familiar headache3 in the temple area with at least 1 of the following     
provocation tests:  
a. Palpation of the temporalis muscle(s), OR 
b. Maximum unassisted or assisted opening, right or left lateral movements, or 
protrusive movements 
EXAM 
Validity Sensitivity 0.89; Specificity 0.87 
Comments The headache is not better accounted for by another headache diagnosis. 
Footnote * A diagnosis of painful TMD (myalgia, myofascial pain with referral, or TMJ arthralgia) is 
derived using valid diagnostic criteria.  
 Table 2. Diagnostic Criteria for the Most Common  
Intra-articular Temporomandibular Disorders 
 
Disc Displacement with Reduction (ICD-9 524.63) 
Description 
An intra-capsular biomechanical disorder involving the condyle-disc complex. In the closed  
mouth position the disc is in an anterior position relative to the condylar head and the disc  
reduces upon opening of the mouth. Medial and lateral displacement of the disc may also be  
present. Clicking, popping or snapping noises may occur with disc reduction. 
 
Cr
ite
ria
 
HISTORY In the last 30 days,
1 any TMJ noise(s) present with jaw movement. 
AND 1. Clicking, popping and/or snapping noise detected during both opening and closing, with 
palpation during at least 1 of 3 repetitions of jaw opening and closing, 
OR 
2. Clicking, popping and/or snapping noise detected with palpation during at least 1 of 3 
repetitions of opening or closing; AND 
3. Clicking, popping and/or snapping noise detected with palpation during at least 1 of 3 
repetitions of right or left lateral movements, or protrusive movements. 
 
 
EXAM 
Validity Without imaging: sensitivity 0.33; specificity 0.94.   
Imaging is the reference standard for this diagnosis. 
 
Imaging 
When this diagnosis needs to be confirmed, then TMJ MRI criteria2 are positive for both of the 
following: 
1. In the maximum intercuspal position, the posterior band of the disc is located anterior to 
the 11:30 position and the intermediate zone of the disc is anterior to the condylar head; 
AND  
2. On full opening, the intermediate zone of the disc is located between the condylar head 
and the articular eminence. 
 
 
Disc Displacement with Reduction with Intermittent Locking (ICD-9 524.63) 
Description 
An intra-capsular biomechanical disorder involving the condyle-disc complex. In the closed 
mouth position the disc is in an anterior position relative to the condylar head, and the disc 
intermittently reduces with opening of the mouth. When the disc does not reduce with opening 
of the mouth, intermittent limited mandibular opening occurs. When limited opening occurs, a 
maneuver may be needed to unlock the TMJ. Medial and lateral displacement of the disc may 
also be present. Clicking, popping or snapping noises may occur with disc reduction. 
 
Cr
ite
ria
 
HISTORY 1. In the last 30 days,
1 any TMJ noise(s) present with jaw movement; AND 
2. In the last 30 days,1 jaw locks with limited mouth opening, even for a moment, and then 
unlocks.  AND Same as specified for Disc Displacement with Reduction.  Although not required, when this 
disorder is present clinically, examination is positive for inability to open to a normal amount, 
even momentarily, without the clinician or patient performing a specific manipulative 
maneuver. 
 
EXAM 
Validity Without imaging: sensitivity 0.46; specificity 0.97. 
Imaging is the reference standard for this diagnosis. 
 
Imaging 
When this diagnosis needs to be confirmed, then the imaging criteria2 are the same as for 
disc displacement with reduction if intermittent locking is not present at the time of imaging. If 
locking occurs during imaging, then an imaging-based diagnosis of disc displacement without 
reduction will be rendered and clinical confirmation of reversion to intermittent locking is 
needed.  
  
 
Disc Displacement without Reduction with Limited Opening (ICD-9 524.63) 
Description 
An intra-capsular biomechanical disorder involving the condyle-disc complex. In the closed 
mouth position the disc is in an anterior position relative to the condylar head, and the disc 
does not reduce with opening of the mouth. Medial and lateral displacement of the disc may 
also be present. This disorder is associated with persistent limited mandibular opening that 
does not resolve with the clinician or patient performing a specific manipulative maneuver. 
This is also referred to as “closed lock”.  
 
Cr
ite
ria
 HISTORY 1. Jaw lock or catch so that the mouth would not open all the way; AND 2. Limitation in jaw opening severe enough to limit jaw opening and interfere with ability to 
eat. 
AND Maximum assisted opening (passive stretch) < 40mm including vertical incisal overlap. 
EXAM 
Validity Without imaging: sensitivity 0.80; specificity 0.97. 
Imaging is the reference standard for this diagnosis. 
Imaging 
When this diagnosis needs to be confirmed, then TMJ MRI criteria2 are positive for both of the 
following:  
1. In the maximum intercuspal position, the posterior band of the disc is located anterior to the 
11:30 position and the intermediate zone of the disc is anterior to the condylar head, 
AND  
2. On full opening, the intermediate zone of the disc is located anterior to the condylar head.  
Note: Maximum assisted opening of < 40mm is determined clinically. 
 
Footnote Presence of TMJ noise (e.g., click with full opening) does not exclude this diagnosis. 
 
Disc Displacement without Reduction without Limited Opening (ICD-9 524.63) 
Description 
An intra-capsular biomechanical disorder involving the condyle-disc complex. In the closed  
mouth position the disc is in an anterior relative the condylar head and the disc does not  
reduce with opening of the mouth. Medial and lateral displacement of the disc may also be  
present. This disorder is NOT associated with limited mandibular opening. 
 
Cr
ite
ria
 HISTORY 
Same as specified for Disc Displacement without Reduction with Limited Opening. 
AND Maximum assisted opening (passive stretch) > 40mm including vertical incisal overlap. 
 EXAM 
Validity Without imaging: sensitivity 0.54; specificity 0.79. 
Imaging is the reference standard for this diagnosis.  
Imaging 
When this diagnosis needs to be confirmed, then TMJ MRI criteria2 are the same as for  
disc displacement without reduction with limited opening.   
Note: Maximum assisted opening of ≥ 40mm is determined clinically. 
 
Footnote Presence of TMJ noise (e.g., click with full opening) does not exclude this diagnosis. 
  1 The time frame for assessing these biomechanical intra-articular disorders is in “the last 30 days” since the stated 
sensitivity and specificity of these criteria was established using this time frame. Although the specific time frame can 
be dependent on the context in which the pain complaint is being assessed, the validity of this diagnosis based on 
different time frames has not been established. 
 
2 Ahmad M, Hollender L, John M, Anderson Q, Kartha K, Ohrbach R, Truelove, E and Schiffman E. Research 
Diagnostic Criteria for Temporomandibular Disorders: Development of Image Analysis Criteria and Examiner 
Reliability for Image Analysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009;107:844-860. 
 
 
Degenerative Joint Disease (ICD-9 715.18) 
Description A degenerative disorder involving the joint characterized by deterioration of articular tissue with concomitant osseous changes in the condyle and/or articular eminence. 
Cr
ite
ria
 
HISTORY In the last 30 days,
1 any TMJ noise(s) present.  
AND At least one of the following must be present: 
1. Crepitus detected with palpation during opening, closing, lateral, or protrusive movements; 
OR 
2. Patient report of crepitus (e.g., crunching, grinding or grating noises) during the exam. EXAM 
Validity Without imaging: sensitivity 0.49; specificity 0.86. 
Imaging is the reference standard for this diagnosis. 
Imaging 
When this disorder is present, then TMJ CT criteria2 are positive for at least one of the 
following: Subchondral cyst(s), erosion(s), generalized sclerosis or osteophyte(s). Note: 
Flattening and/or cortical sclerosis are considered indeterminant findings for DJD and may 
represent normal variation, aging, remodeling or a precursor to frank DJD. 
 
 
 Subluxation (ICD-9 830.0) 
Description 
A hypermobility disorder involving the disc-condyle complex and the articular eminence: In 
the open mouth position, the disc-condyle complex is positioned anterior to the articular 
eminence and is unable to return to a normal closed mouth position without a specific 
manipulative maneuver. The duration of dislocation may be momentary or prolonged.  When 
prolonged the patient may need the assistance of the clinician to reduce the dislocation and 
normalize jaw movement.  This is also referred to as “open lock”.  
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HISTORY 
1. In last 30 days,1 jaw locking or catching in a wide open mouth position, even for a moment, 
so could not close from the wide open position, AND  
2. Inability to close the mouth without a specific manipulative maneuver  
AND Although no exam findings are required, when this disorder is present clinically, examination  
is positive for inability to return to a normal closed mouth position without the clinician or 
patient performing a specific manipulative maneuver. 
EXAM 
Validity Without imaging and based only on history: sensitivity 0.98; specificity 1.00. 
Imaging 
When this disorder is present, then imaging criteria are positive for the condyle positioned 
beyond the height of the articular eminence. 
 
 Table 3. Taxonomic Classification for Temporomandibular Disorders 
 
I. TEMPOROMANDIBULAR JOINT DISORDERS  
1.  Joint pain 
A. Arthralgia 
B. Arthritis  
2. Joint disorders 
A.  Disc-condyle complex disorders  
1. Disc displacement with reduction  
2. Disc displacement with reduction with intermittent locking  
3. Disc displacement without reduction with limited opening 
4. Disc displacement without reduction without limited opening 
B. Hypomobility disorders   
1. Adhesions / Adherence  
2. Ankylosis  
a. Fibrous  
b. Osseous  
C. Hypermobility disorders/ dislocation 
1. Subluxation  
2. Luxation   
3. Joint diseases 
A. Degenerative joint disease  
1. Osteoarthritis  
2. Osteoarthrosis  
B. Condylar resorption/condylysis  
C. TMD attributed to systemic arthritides  
1. Rheumatoid arthritis 
2. Juvenile idiopathic arthritis  
3. Metabolic arthritis 
4. Other 
D. Neoplasm  
E. Chondromatosis  
4. Fractures  
5. Congenital/developmental disorders  
A. Aplasia  
B. Hypoplasia  
C. Hyperplasia 
 II. MASTICATORY MUSCLE DISORDERS 
1. Muscle pain  
A. Myalgia   
1. Local myalgia  
2. Myofascial pain  
3. Myofascial pain with referral  
B. Tendonitis  
C. Spasm 
D. Myositis 
2. Contracture  
3. Hypertrophy 
4. Neoplasm 
5. Movement Disorders 
 A. Dyskinesia  
 B. Dystonia 
6.  Masticatory muscle pain attributed to systemic/central pain disorders 
A.  Fibromyalgia/ widespread pain 
B. Centrally mediated regional myalgia 
 
III. Headache  
1. Headache attributed to TMD  
 
IV. Associated structures  
1. Coronoid hyperplasia 
 
 
Table 4.  From RDC/TMD to DC/TMD: Changes in diagnostic algorithms for pain-related 
TMD  
 RDC/TMD DC/TMD 
HISTORY  
(applicable to all pain-related TMD disorders) 
 Presence of masticatory system pain in past 30 days ✓ ✓ 
 Pain modification with jaw movement, function, or parafunction  ✓ 
EXAMINATION 
Arthralgia 
 Confirmation of location of pain in the joint  ✓ 
 Pain with joint palpation 
• Lateral pole 
• Around lateral pole  
• Posterior site 
 
✓ 
 
✓ 
 
✓ 
✓ 
 
 Familiar pain with palpation   ✓ 
 Familiar pain with range of motion  ✓ 
Myalgia (“Myofascial pain” in RDC/TMD) 
 Confirmation of location of pain in a masticatory muscle  ✓ 
 Pain with muscle palpation   
• Temporalis ✓ ✓ 
• Masseter ✓ ✓ 
• Posterior mandibular region ✓  
• Submandibular region ✓  
• Lateral pterygoid area ✓  
• Temporalis tendon ✓  
 Pain with maximum unassisted or assisted opening  ✓ 
 Familiar pain with palpation or opening  ✓ 
Myofascial pain with referral (new diagnosis) 
Sustained palpation with identification of referral patterns  ✓ 
 
 
 
Table 5. From RDC/TMD to DC/TMD: Changes in diagnostic algorithms for disc 
displacements and degenerative joint disease with new history - based diagnosis of 
subluxation. 
 RDC/TMD DC/TMD 
HISTORY 
 “In last 30 days, any noise present” pertains to disc displacement with 
reduction with and without intermittent locking, and degenerative joint 
disease. 
 ✓ 
 “In last month, jaw locks with limited mouth opening and then unlocks” 
pertains to disc displacement with reduction with intermittent locking 
 ✓ 
 “Jaw lock or catch so that it would not open all the way” pertains to disc 
displacement without reduction with and without limited opening 
 ✓ 
“When you opened your mouth wide, jaw lock or catch so that it would 
not close all the way” pertains to subluxation.  
 ✓ 
EXAMINATION 
Disc Displacement with Reduction 
 Click detection 2 of 3 1 of 3 
 5mm between reciprocal clicks ✓  
 Elimination of click in protrusive position ✓  
Disc Displacement with Reduction, with Intermittent Locking 
 
✓ 
Disc Displacement without Reduction, with Limited Opening 
 Unassisted opening of ≤ 35mm and assisted opening ≤ 4mm more than 
unassisted opening 
✓  
 Assisted opening < 40mm  ✓ 
 Contralateral movements < 7mm and/or uncorrected deviation to the 
ipsilateral side on opening 
✓  
 Absence of noise, or noise not meeting criteria for disc displacement 
with reduction 
✓   
Disc Displacement without Reduction, without Limited Opening 
 Unassisted opening > 35mm and assisted opening > 4mm more than 
unassisted opening  
✓  
 Assisted opening ≥ 40mm  ✓ 
 Contralateral and protrusive movements ≥ 7mm ✓  
 Noise not meeting criteria for disc displacement with reduction ✓  
Degenerative Joint Disease 
 Coarse crepitus with palpation ✓  
 Crepitus (fine or coarse) with palpation  ✓ 
 Crepitus reported by patient with range of motion  ✓ 
 
 
Table 6.  Recommended Axis II Assessment Protocol 
Domain Instrument # items Screening Comprehensive 
Pain intensity Graded Chronic Pain 3 ✔ ✔ 
Pain locations Pain drawing 1 ✔ ✔ 
Physical function Graded Chronic Pain 4 ✔ ✔ 
Limitation JFLS-short form 8 ✔  
 JFLS-long form 20  ✔ 
Distress PHQ-4 5 ✔  
 PHQ-9* 10  ✔ 
Anxiety GAD-7 7  ✔ 
Physical symptoms PHQ-15* 15  ✔ 
Parafunction Oral Behaviors 
Checklist 
21 ✔ ✔ 
* The RDC/TMD depression and non-specific physical symptoms instruments could be 
substituted for the PHQ-9 and PHQ-15, respectively, if continuity with legacy data is 
important.  
 
Table 7. Clinical and Research Applications of Selected DC/TMD Axis I and 
Axis II Tests 
 Axis I: Physical Diagnosis Axis II: Psychosocial Status 
 Pain Diagnoses Joint Diagnoses Distress and Pain Disability 
Application Clinical or Research Clinical Clinical or Research 
Screening 
Test 
TMD Pain 
Screener 
DC/TMD for 
DD, DJD and 
Dislocation 
PHQ-4 
GCPS 
PHQ-9 
GAD-7 
PHQ-15 
GCPS 
Confirmatory 
Test 
DC/TMD for 
Arthralgia, 
Myofascial Pain 
and Headache 
attributed to 
TMD 
Imaging: 
MRI for DD and 
CT for DJD 
Consultation 
with Mental 
Health Provider 
Structured 
Psychiatric or 
Behavioral 
Medicine 
Interview 
 
